IGC Pharma Inc (IGC)

NYSE
Currency in USD
0.3058
-0.0006(-0.20%)
Closed
After Hours
0.3001-0.0056(-1.8319%)
IGC Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
0.30240.3097
52 wk Range
0.26080.9099
Key Statistics
Edit
Prev. Close
0.3064
Open
0.3042
Day's Range
0.3024-0.3097
52 wk Range
0.2608-0.9099
Volume
61.78K
Average Volume (3m)
397.72K
1-Year Change
-23.55%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IGC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.8750
Upside
+1,167.17%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

IGC Pharma Inc Company Profile

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer’s disease. The company’s lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer’s; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Compare IGC to Peers and Sector

Metrics to compare
IGC
Peers
Sector
Relationship
P/E Ratio
−2.8x−0.7x−0.5x
PEG Ratio
−0.050.000.00
Price/Book
3.9x0.7x2.6x
Price / LTM Sales
19.7x1.2x3.0x
Upside (Analyst Target)
-255.5%55.6%
Fair Value Upside
Unlock23.4%10.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.8750
(+1,167.17% Upside)

Earnings

Latest Release
Feb 18, 2025
EPS / Forecast
-0.02 / -0.03
Revenue / Forecast
257.00K / 204.00K
EPS Revisions
Last 90 days

People Also Watch

0.033
SYRS
-17.50%
0.67
AEON
-6.91%
6.9600
ADTX
-2.93%
1.6500
NWTG
-4.62%
1.430
PSTV
+25.44%

FAQ

What Is the IGC Pharma (IGC) Stock Price Today?

The IGC Pharma stock price today is 0.3058

What Stock Exchange Does IGC Pharma Trade On?

IGC Pharma is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for IGC Pharma?

The stock symbol for IGC Pharma is "IGC."

What Is the IGC Pharma Market Cap?

As of today, IGC Pharma market cap is 24.41M.

What is IGC Pharma Earnings Per Share?

The IGC Pharma EPS is -0.121.

What Is the Next IGC Pharma Earnings Date?

IGC Pharma will release its next earnings report on 17 June 2025.

From a Technical Analysis Perspective, Is IGC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.